These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 35068291)

  • 1. An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
    Ali M; Chen HY; Chiang YF; Badary OA; Hsia SM; Al-Hendy A
    Expert Opin Pharmacother; 2022 Mar; 23(4):421-429. PubMed ID: 35068291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.
    Syed YY
    Drugs; 2022 Oct; 82(15):1549-1556. PubMed ID: 36331779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; Critchley HOD; Li Y; McKain L; Arjona Ferreira JC; Langenberg AGM; Wagman RB; Stewart EA
    N Engl J Med; 2021 Feb; 384(7):630-642. PubMed ID: 33596357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
    Ali M; A R S; Al Hendy A
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):427-437. PubMed ID: 33682578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
    Stewart EA; Al-Hendy A; Lukes AS; Madueke-Laveaux OS; Zhu E; Proehl S; Schulmann T; Marsh EE
    Am J Obstet Gynecol; 2024 Feb; 230(2):237.e1-237.e11. PubMed ID: 37863160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids.
    Ali M; Raslan M; Ciebiera M; Zaręba K; Al-Hendy A
    Expert Opin Drug Saf; 2022 Apr; 21(4):477-486. PubMed ID: 34612122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
    Osuga Y; Enya K; Kudou K; Tanimoto M; Hoshiai H
    Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis.
    Arjona Ferreira JC; Migoya E
    F S Rep; 2023 Jun; 4(2 Suppl):73-82. PubMed ID: 37223761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
    Al-Hendy A; Venturella R; Arjona Ferreira JC; Li Y; Soulban G; Wagman RB; Lukes AS
    Am J Obstet Gynecol; 2023 Dec; 229(6):662.e1-662.e25. PubMed ID: 37666383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
    Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Carr BR; Stewart EA; Archer DF; Al-Hendy A; Bradley L; Watts NB; Diamond MP; Gao J; Owens CD; Chwalisz K; Duan WR; Soliman AM; Dufek MB; Simon JA
    Obstet Gynecol; 2018 Nov; 132(5):1252-1264. PubMed ID: 30303923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relugolix for the treatment of uterine fibroids.
    Rocca ML; Palumbo AR; Lico D; Fiorenza A; Bitonti G; D'Agostino S; Gallo C; Di Carlo C; Zullo F; Venturella R
    Expert Opin Pharmacother; 2020 Oct; 21(14):1667-1674. PubMed ID: 32674616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain.
    Blair HA
    Drugs; 2024 Apr; 84(4):449-457. PubMed ID: 38592603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
    Obstet Gynecol; 2022 Dec; 140(6):920-930. PubMed ID: 36357960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis.
    Muhammad J; Yusof Y; Ahmad I; Norhayati MN
    BMC Womens Health; 2022 Jan; 22(1):14. PubMed ID: 35033041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.
    Stewart EA; Lukes AS; Venturella R; Arjona Ferreira JC; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Obstet Gynecol; 2022 Jun; 139(6):1070-1081. PubMed ID: 35675604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).
    Kitade M; Kumakiri J; Kobori H; Murakami K
    Trials; 2024 May; 25(1):343. PubMed ID: 38790029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids.
    Lynch SE; Mayer DC
    Ann Pharmacother; 2022 Jan; 56(1):93-101. PubMed ID: 33998300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.
    Al-Hendy A; Lukes AS; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
    J Comp Eff Res; 2023 Aug; 12(8):e230069. PubMed ID: 37477173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myfembree for fibroid-associated heavy menstrual bleeding.
    Med Lett Drugs Ther; 2021 Aug; 63(1630):121-123. PubMed ID: 34550666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.